CN117794519A - 非层状液晶形成性组合物及其用途 - Google Patents

非层状液晶形成性组合物及其用途 Download PDF

Info

Publication number
CN117794519A
CN117794519A CN202280052806.8A CN202280052806A CN117794519A CN 117794519 A CN117794519 A CN 117794519A CN 202280052806 A CN202280052806 A CN 202280052806A CN 117794519 A CN117794519 A CN 117794519A
Authority
CN
China
Prior art keywords
liquid crystal
fatty acid
lamellar liquid
composition
acid ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280052806.8A
Other languages
English (en)
Chinese (zh)
Inventor
杉林坚次
藤堂浩明
板仓祥子
土黑一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farnex Inc
Original Assignee
Farnex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farnex Inc filed Critical Farnex Inc
Publication of CN117794519A publication Critical patent/CN117794519A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/061—Linear compounds without any rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K2019/528—Surfactants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2219/00—Aspects relating to the form of the liquid crystal [LC] material, or by the technical area in which LC material are used
    • C09K2219/15—Aspects relating to the form of the liquid crystal [LC] material, or by the technical area in which LC material are used used as a medium, in which chemical reactions take place

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
CN202280052806.8A 2021-07-27 2022-07-27 非层状液晶形成性组合物及其用途 Pending CN117794519A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021122489 2021-07-27
JP2021-122489 2021-07-27
PCT/JP2022/029014 WO2023008498A1 (ja) 2021-07-27 2022-07-27 非ラメラ液晶形成性組成物及びその用途

Publications (1)

Publication Number Publication Date
CN117794519A true CN117794519A (zh) 2024-03-29

Family

ID=85086981

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280052806.8A Pending CN117794519A (zh) 2021-07-27 2022-07-27 非层状液晶形成性组合物及其用途

Country Status (5)

Country Link
US (1) US20240327709A1 (https=)
EP (1) EP4378452A4 (https=)
JP (1) JPWO2023008498A1 (https=)
CN (1) CN117794519A (https=)
WO (1) WO2023008498A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
MX350929B (es) * 2011-12-05 2017-09-26 Camurus Ab Formulaciones peptidicas robustas de liberación controlada.
WO2014178256A1 (ja) * 2013-05-01 2014-11-06 株式会社ファルネックス 癒着防止剤
CN107257681A (zh) 2014-12-23 2017-10-17 卡姆拉斯公司 控释配制品
US10294238B2 (en) * 2015-04-24 2019-05-21 Basf Se Isosorbide diester as pearlizing agent and opacifier
CN105613493A (zh) * 2016-02-24 2016-06-01 深圳百乐宝生物农业科技有限公司 一种丙二醇单脂肪酸酯作为杀螨剂的用途和杀螨剂及应用
US20210355291A1 (en) * 2018-10-04 2021-11-18 Takemoto Yushi Kabushiki Kaisha Modifier for polyolefin resin
JP6969726B2 (ja) 2020-02-05 2021-11-24 株式会社コナミアミューズメント ゲームシステム、管理システム、プログラム及びゲームシステムの動作方法

Also Published As

Publication number Publication date
WO2023008498A1 (ja) 2023-02-02
EP4378452A4 (en) 2025-07-23
JPWO2023008498A1 (https=) 2023-02-02
US20240327709A1 (en) 2024-10-03
EP4378452A1 (en) 2024-06-05

Similar Documents

Publication Publication Date Title
RU2632433C2 (ru) Липидный преконцентрат с замедленным высвобождением фармакологически активного вещества и фармацевтическая композиция, содержащая его
RU2649810C2 (ru) Липидный предконцентрат катионного фармакологически активного вещества с длительным высвобождением и содержащая его фармацевтическая композиция
ES2400034T3 (es) Formulaciones bioadhesivas tópicas
AU2013371101B2 (en) Sustained-release lipid pre-concentrate of GnRH analogues and pharmaceutical composition comprising the same
RU2664700C2 (ru) Депо-составы местного анестетика и способы их получения
EP2992910A1 (en) Adhesion preventing agent
ES2296218T5 (es) Composición de tipo emulsión inversa que contiene calcitriol y 17-propionato de clobetasol y su utilización en cosmètica y en dermatología.
PT1545757E (pt) Emulsões perfluorcarbonadas com tensioactivos não fluorados
AU2013371098B2 (en) Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the same
JP2025183306A (ja) イオン液体、溶媒、製剤および経皮吸収剤
CN112384201A (zh) 局部组合物
JP2026511974A (ja) タクロリムスの安定性と皮膚浸透性を改善したナノエマルション製剤
KR20150004798A (ko) 소포성 제형
CN117794519A (zh) 非层状液晶形成性组合物及其用途
JP2019193684A (ja) 油分を含むエマルションを用いた癒着防止剤
JP7731501B2 (ja) 水性ゲル組成物
CN115461084B (zh) 安全性高的非层状液晶形成性组合物
CN112190504B (zh) 一种含有玫瑰精油的长效液体凝胶及其制备方法和应用
WO2014090858A1 (en) Gel compositions
WO2018043731A1 (ja) 油分を含むエマルションを用いた癒着防止剤
KR102745034B1 (ko) 수분 감응성 졸-겔 상전이 기반 유착방지용 조성물
JP2022092861A (ja) セラミド含有リポソーム
WO2019088274A1 (ja) 医薬組成物、医薬組成物の安定化方法、及び医薬組成物の保存安定性を評価する方法
CN109985005A (zh) 氟比洛芬酯脂肪乳及其制备方法
Sguizzato Nanotechnological strategies for topical administration of active compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination